REPORT ID 2920

Global Neurological Disorder Drugs Market ResearchReport 2019

Publish Date
2019
Pages
106
Format
Electronic (PDF)

In this report, the global Neurological Disorder Drugs market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Neurological Disorder Drugs in these regions, from   2019 to 2025 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Neurological Disorder Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Novartis AG
    GlaxoSmithKline plc
    Merck & Co.
    Bayer AG
    AstraZeneca
    Boehringer Ingelheim GmbH
    Teva Pharmaceutical Industries Ltd.
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Antipsychotic
    Hypnotic & Sedative
    Analgesics
    Anticoagulants
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Clinic
    Home

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Neurological Disorder Drugs Market Research  Report 2019
1 Neurological Disorder Drugs Market Overview
    1.1 Product Overview and Scope of Neurological Disorder Drugs
    1.2 Neurological Disorder Drugs Segment by Type (Product Category)
        1.2.1 Global Neurological Disorder Drugs Production and CAGR (%) Comparison by Type (Product Category)( 2014-2024)
        1.2.2 Global Neurological Disorder Drugs Production Market Share by Type (Product Category)  in 2018
        1.2.3 Antipsychotic
        1.2.4 Hypnotic & Sedative
        1.2.5 Analgesics
        1.2.6 Anticoagulants
        1.2.7 Others
    1.3 Global Neurological Disorder Drugs Segment by Application
        1.3.1 Neurological Disorder Drugs Consumption (Sales) Comparison by Application ( 2014-2024)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home
    1.4 Global Neurological Disorder Drugs Market by Region ( 2014-2024)
        1.4.1 Global Neurological Disorder Drugs Market Size (Value) and CAGR (%) Comparison by Region ( 2014-2024)
        1.4.2 North America Status and Prospect ( 2014-2024)
        1.4.3 Europe Status and Prospect ( 2014-2024)
        1.4.4 China Status and Prospect ( 2014-2024)
        1.4.5 Japan Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.7 India Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value) of Neurological Disorder Drugs ( 2014-2024)
        1.5.1 Global Neurological Disorder Drugs Revenue Status and Outlook ( 2014-2024)
        1.5.2 Global Neurological Disorder Drugs Capacity, Production Status and Outlook ( 2014-2024)

2 Global Neurological Disorder Drugs Market Competition by Manufacturers
    2.1 Global Neurological Disorder Drugs Capacity, Production and Share by Manufacturers ( 2014-2019)
        2.1.1 Global Neurological Disorder Drugs Capacity and Share by Manufacturers ( 2014-2019)
        2.1.2 Global Neurological Disorder Drugs Production and Share by Manufacturers ( 2014-2019)
    2.2 Global Neurological Disorder Drugs Revenue and Share by Manufacturers ( 2014-2019)
    2.3 Global Neurological Disorder Drugs Average Price by Manufacturers ( 2014-2019)
    2.4 Manufacturers Neurological Disorder Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Neurological Disorder Drugs Market Competitive Situation and Trends
        2.5.1 Neurological Disorder Drugs Market Concentration Rate
        2.5.2 Neurological Disorder Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Neurological Disorder Drugs Capacity, Production, Revenue (Value) by Region ( 2014-2019)
    3.1 Global Neurological Disorder Drugs Capacity and Market Share by Region ( 2014-2019)
    3.2 Global Neurological Disorder Drugs Production and Market Share by Region ( 2014-2019)
    3.3 Global Neurological Disorder Drugs Revenue (Value) and Market Share by Region ( 2014-2019)
    3.4 Global Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.5 North America Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.6 Europe Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.7 China Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.8 Japan Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.9 Southeast Asia Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.10 India Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)

4 Global Neurological Disorder Drugs Supply (Production), Consumption, Export, Import by Region ( 2014-2019)
    4.1 Global Neurological Disorder Drugs Consumption by Region ( 2014-2019)
    4.2 North America Neurological Disorder Drugs Production, Consumption, Export, Import ( 2014-2019)
    4.3 Europe Neurological Disorder Drugs Production, Consumption, Export, Import ( 2014-2019)
    4.4 China Neurological Disorder Drugs Production, Consumption, Export, Import ( 2014-2019)
    4.5 Japan Neurological Disorder Drugs Production, Consumption, Export, Import ( 2014-2019)
    4.6 Southeast Asia Neurological Disorder Drugs Production, Consumption, Export, Import ( 2014-2019)
    4.7 India Neurological Disorder Drugs Production, Consumption, Export, Import ( 2014-2019)

5 Global Neurological Disorder Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Neurological Disorder Drugs Production and Market Share by Type ( 2014-2019)
    5.2 Global Neurological Disorder Drugs Revenue and Market Share by Type ( 2014-2019)
    5.3 Global Neurological Disorder Drugs Price by Type ( 2014-2019)
    5.4 Global Neurological Disorder Drugs Production Growth by Type ( 2014-2019)

6 Global Neurological Disorder Drugs Market Analysis by Application
    6.1 Global Neurological Disorder Drugs Consumption and Market Share by Application ( 2014-2019)
    6.2 Global Neurological Disorder Drugs Consumption Growth Rate by Application ( 2014-2019)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Neurological Disorder Drugs Manufacturers Profiles/Analysis
    7.1 Novartis AG
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Neurological Disorder Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Novartis AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.1.4 Main Business/Business Overview
    7.2 GlaxoSmithKline plc
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Neurological Disorder Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.2.4 Main Business/Business Overview
    7.3 Merck & Co.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Neurological Disorder Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Merck & Co. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.3.4 Main Business/Business Overview
    7.4 Bayer AG
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Neurological Disorder Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Bayer AG Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.4.4 Main Business/Business Overview
    7.5 AstraZeneca
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Neurological Disorder Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 AstraZeneca Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.5.4 Main Business/Business Overview
    7.6 Boehringer Ingelheim GmbH
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Neurological Disorder Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.6.4 Main Business/Business Overview
    7.7 Teva Pharmaceutical Industries Ltd.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Neurological Disorder Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.7.4 Main Business/Business Overview
    ...

8 Neurological Disorder Drugs Manufacturing Cost Analysis
    8.1 Neurological Disorder Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Neurological Disorder Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Neurological Disorder Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Neurological Disorder Drugs Market Forecast ( 2019-2025)
    12.1 Global Neurological Disorder Drugs Capacity, Production, Revenue Forecast ( 2019-2025)
        12.1.1 Global Neurological Disorder Drugs Capacity, Production and Growth Rate Forecast ( 2019-2025)
        12.1.2 Global Neurological Disorder Drugs Revenue and Growth Rate Forecast ( 2019-2025)
        12.1.3 Global Neurological Disorder Drugs Price and Trend Forecast ( 2019-2025)
    12.2 Global Neurological Disorder Drugs Production, Consumption , Import and Export Forecast by Region ( 2019-2025)
        12.2.1 North America Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.2 Europe Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.3 China Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.4 Japan Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.5 Southeast Asia Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.6 India Neurological Disorder Drugs Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
    12.3 Global Neurological Disorder Drugs Production, Revenue and Price Forecast by Type ( 2019-2025)
    12.4 Global Neurological Disorder Drugs Consumption Forecast by Application ( 2019-2025)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer